Insulin glargine Ezelin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Insulin glargine Ezelin, covering 2020-04-01 to 2020-04-01. Get the full timeline:
Most recent: Clinical Trial Update: Immunogenicity Study of Insulin Glargine Ezelin vs Lantus in Type 2 Diabetes Mellitus Patients [Phase 2]